Literature DB >> 29700131

Complete Genome Sequences of Two Novel Staphylococcus aureus Podoviruses of Potential Therapeutic Use, vB_SauP_phiAGO1.3 and vB_SauP_phiAGO1.9.

Agnieszka Gozdek1, Aleksandra Głowacka-Rutkowska1, Jan Gawor2, Joanna Empel3, Robert Gromadka2, Małgorzata B Łobocka4,5.   

Abstract

Here, we report the genome sequences of two Staphylococcus aureus phages belonging to the family Podoviridae and subfamily Picovirinae, vB_SauP_phiAGO1.3 and vB_SauP_phiAGO1.9, which were isolated from Warsaw sewage. Analysis of their genomes provides valuable information about the diversity of phages belonging to the genus Rosenblumvirus and their genes that undergo evolutionary adaptation to cells of different host strains.
Copyright © 2018 Gozdek et al.

Entities:  

Year:  2018        PMID: 29700131      PMCID: PMC5920172          DOI: 10.1128/genomeA.00048-18

Source DB:  PubMed          Journal:  Genome Announc


GENOME ANNOUNCEMENT

Phage therapy is a promising alternative to antibiotic therapy in the treatment of infections with antibiotic-resistant Staphylococcus aureus (1). The possibility of its use depends on the availability of phages against a given infecting strain. Lytic phages vB_SauP_phiAGO1.3 (phiAGO1.3) and vB_SauP_phiAGO1.9 (phiAGO1.9) were isolated in September 2009 from sewage at the Warsaw sewage farm Czajka using a standard procedure (2) with 14 different S. aureus strains. Both phages infected 11 of the same strains. A strain from the collection of the National Medicines Institute (NMI) (2064/05) was used as a phage propagator. It belongs to clonal complex 9 (CC9) and was isolated from cerebrospinal fluid of a patient diagnosed with invasive infection. Phages for DNA sequencing were precipitated using polyethylene glycol and NaCl from DNase- and RNase-treated cell lysates as described previously (3). DNA was extracted by using the SDS-proteinase K method (4) and sequenced at the Laboratory of Sequencing and Oligonucleotide Synthesis of the Institute of Biochemistry and Biophysics of the Polish Academy of Sciences (IBB PAS) using standard shotgun sequencing reagents and the Titanium 454 GS-FLX genome sequencer (Roche). The Lasergene version 9.1 software program (DNAStar, Inc.) was used for the sequence assembly, which resulted in 80 to 91× coverage. Ambiguous sequence regions were amplified with specific primers and resequenced using the ABI PRISM dye terminator cycle sequencing ready reaction kit with AmpliTaq DNA polymerase, FS (Perkin Elmer), and ABI 377 automated sequencers (Perkin Elmer). The correctness of the sequence assembly was verified by comparison of in silico and in vivo patterns of DNA digestion with PagI. Ends of virion DNA were identified by analyzing the PagI restriction pattern of phage DNA treated with BalI endonuclease, as described previously (5). Terminal repeat regions were resequenced by Sanger sequencing with virion DNA as a template and primers complementary to the nonredundant parts of the end regions (5′-GTTGCAACATTTCAGTATATGCTTG and 5′-GTTTTCGTTTTCTTCTTCGATTG). The genomes were annotated with the use of the Rapid Annotations using Subsystems Technology (RAST) server (6, 7). The genomes of phiAGO1.3 and phiAGO1.9 consist of 17,603 and 17,637 bp, respectively, with an average GC content of 28.96%, which is lower than that of S. aureus (32.7%). Virion DNA molecules of both phages end with inverted terminal repeats (ITRs) that are perfect over the first 116 bp from each end, except for one mismatch, and less perfect until position 344 of the left ITR. The genomic sequences of phiAGO1.3 and phiAGO1.9 are nearly identical, with both phages encoding 20 proteins. Differences at the DNA level are limited to single mismatches in the region of the ITRs and the presence in open reading frame 20 (ORF20) in phiAGO1.9 of an additional 36-bp sequence repeat. Due to the insertion, the products of phiAGO1.3 and phiAGO1.9 ORF20 differ by 12 amino acid residues. At the genomic level, both phages are 91% identical to the staphylococcal podoviruses GRCS (8), BP39 (GenBank accession number KM366100), and SAP-2 (9) belonging to the Rosenblumvirus genus; they are also similar to other phages in this genus, although to a lesser extent. Significant differences concern proteins associated with phage-host interactions, namely, the minor tail fiber, the peptidoglycan-binding protein, amidase, and phage lysin, suggesting that phiAGO1.3 and phiAGO1.9 differ from their relatives in strain specificity.

Accession number(s).

The genome sequences of S. aureus phages vB_SauP_phiAGO1.3 and vB_SauP_phiAGO1.9 were deposited in GenBank under the accession numbers MG766218 and MG766219, respectively.
  8 in total

1.  Potential of bacteriophages and their lysins in the treatment of MRSA: current status and future perspectives.

Authors:  Jan Borysowski; Małgorzata Lobocka; Ryszard Międzybrodzki; Beata Weber-Dabrowska; Andrzej Górski
Journal:  BioDrugs       Date:  2011-12-01       Impact factor: 5.807

2.  Bacteriophage enrichment from water and soil.

Authors:  Rohan Van Twest; Andrew M Kropinski
Journal:  Methods Mol Biol       Date:  2009

Review 3.  Genomics of staphylococcal Twort-like phages--potential therapeutics of the post-antibiotic era.

Authors:  Małgorzata Łobocka; Monika S Hejnowicz; Kamil Dąbrowski; Agnieszka Gozdek; Jarosław Kosakowski; Magdalena Witkowska; Magdalena I Ulatowska; Beata Weber-Dąbrowska; Magdalena Kwiatek; Sylwia Parasion; Jan Gawor; Helena Kosowska; Aleksandra Głowacka
Journal:  Adv Virus Res       Date:  2012       Impact factor: 9.937

4.  Genome of bacteriophage P1.

Authors:  Małgorzata B Łobocka; Debra J Rose; Guy Plunkett; Marek Rusin; Arkadiusz Samojedny; Hansjörg Lehnherr; Michael B Yarmolinsky; Frederick R Blattner
Journal:  J Bacteriol       Date:  2004-11       Impact factor: 3.490

5.  Antibacterial and biofilm removal activity of a podoviridae Staphylococcus aureus bacteriophage SAP-2 and a derived recombinant cell-wall-degrading enzyme.

Authors:  Jee-Soo Son; Se-Jung Lee; Soo Youn Jun; Seong Jun Yoon; Sang Hyeon Kang; Hyoung Rok Paik; Jung Ok Kang; Yun-Jaie Choi
Journal:  Appl Microbiol Biotechnol       Date:  2009-12-15       Impact factor: 4.813

6.  The RAST Server: rapid annotations using subsystems technology.

Authors:  Ramy K Aziz; Daniela Bartels; Aaron A Best; Matthew DeJongh; Terrence Disz; Robert A Edwards; Kevin Formsma; Svetlana Gerdes; Elizabeth M Glass; Michael Kubal; Folker Meyer; Gary J Olsen; Robert Olson; Andrei L Osterman; Ross A Overbeek; Leslie K McNeil; Daniel Paarmann; Tobias Paczian; Bruce Parrello; Gordon D Pusch; Claudia Reich; Rick Stevens; Olga Vassieva; Veronika Vonstein; Andreas Wilke; Olga Zagnitko
Journal:  BMC Genomics       Date:  2008-02-08       Impact factor: 3.969

7.  The SEED and the Rapid Annotation of microbial genomes using Subsystems Technology (RAST).

Authors:  Ross Overbeek; Robert Olson; Gordon D Pusch; Gary J Olsen; James J Davis; Terry Disz; Robert A Edwards; Svetlana Gerdes; Bruce Parrello; Maulik Shukla; Veronika Vonstein; Alice R Wattam; Fangfang Xia; Rick Stevens
Journal:  Nucleic Acids Res       Date:  2013-11-29       Impact factor: 16.971

8.  Complete Genome Sequence of Staphylococcus aureus Phage GRCS.

Authors:  Steven M Swift; Daniel C Nelson
Journal:  Genome Announc       Date:  2014-04-10
  8 in total
  2 in total

1.  The Ability of Lytic Staphylococcal Podovirus vB_SauP_phiAGO1.3 to Coexist in Equilibrium With Its Host Facilitates the Selection of Host Mutants of Attenuated Virulence but Does Not Preclude the Phage Antistaphylococcal Activity in a Nematode Infection Model.

Authors:  Aleksandra Głowacka-Rutkowska; Agnieszka Gozdek; Joanna Empel; Jan Gawor; Karolina Żuchniewicz; Aleksandra Kozińska; Janusz Dębski; Robert Gromadka; Małgorzata Łobocka
Journal:  Front Microbiol       Date:  2019-01-18       Impact factor: 5.640

2.  Isolation and characterization of lytic bacteriophages from sewage at an egyptian tertiary care hospital against methicillin-resistant Staphylococcus aureus clinical isolates.

Authors:  Safia Samir; Amira El-Far; Hend Okasha; Rania Mahdy; Fatima Samir; Sami Nasr
Journal:  Saudi J Biol Sci       Date:  2022-03-19       Impact factor: 4.219

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.